These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7403123)

  • 21. Motor convulsions and EEG during maximal electroshock in the rat.
    Stille G; Sayers A
    Int J Neuropharmacol; 1967 May; 6(3):169-74. PubMed ID: 4382557
    [No Abstract]   [Full Text] [Related]  

  • 22. Anticonvulsant activity of 1-alkyl-4-substituted 3,5-pyrazolidinediones.
    Kornet MJ; Thorstenson JH; Lubawy WC
    J Pharm Sci; 1974 Jul; 63(7):1090-3. PubMed ID: 4850600
    [No Abstract]   [Full Text] [Related]  

  • 23. Anticonvulsant properties of cannabidiol.
    Turkanis SA; Cely W; Olsen DM; Karler R
    Res Commun Chem Pathol Pharmacol; 1974 Jun; 8(2):231-46. PubMed ID: 4850602
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacological properties of N-aminodiphenylhydantoin, a new hydantoin derivative with anticonvulsant activity.
    Rump S; Ilczuk I; Rabsztyn T; Walczyna K
    Pharmazie; 1981 Nov; 36(11):780-1. PubMed ID: 7323129
    [No Abstract]   [Full Text] [Related]  

  • 25. Cholecalciferol enhances the anticonvulsant effect of conventional antiepileptic drugs in the mouse model of maximal electroshock.
    Borowicz KK; Morawska M; Furmanek-Karwowska K; Luszczki JJ; Czuczwar SJ
    Eur J Pharmacol; 2007 Nov; 573(1-3):111-5. PubMed ID: 17643415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of lynestrenol on the rate of metabolism of phenobarbital, phenytoin and hexobarbital in mice.
    Rümke CL; Noordhoek J
    Eur J Pharmacol; 1969 May; 6(2):163-8. PubMed ID: 5796802
    [No Abstract]   [Full Text] [Related]  

  • 27. Isobolographic analysis of interactions between remacemide and conventional antiepileptic drugs in the mouse model of maximal electroshock.
    Borowicz KK; Malek R; Luszczki JJ; Ratnaraj N; Patsalos PN; Czuczwar SJ
    Epilepsy Behav; 2007 Aug; 11(1):6-12. PubMed ID: 17602881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of dihydropyrimidinase in the metabolism of some hydantoin and succinimide drugs.
    Dudley KH; Butler TC; Bius DL
    Drug Metab Dispos; 1974; 2(2):103-12. PubMed ID: 4150990
    [No Abstract]   [Full Text] [Related]  

  • 29. Synthesis and anticonvulsant activity of substituted 2-thioquinazolin-4-ones. I. Preliminary studies.
    Glasser AC; Diamond L; Combs G
    J Pharm Sci; 1971 Jan; 60(1):127-9. PubMed ID: 5548222
    [No Abstract]   [Full Text] [Related]  

  • 30. Intravenous phenytoin and phenobarbital: anticonvulsant action, brain content, and plasma binding in rat.
    Leppik IE; Sherwin AL
    Epilepsia; 1979 Jun; 20(3):201-7. PubMed ID: 446431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Central effect of various new carbamide and succinimide derivatives of benzoxazolone-2].
    Kolasa K; Kleinrok Z
    Acta Pol Pharm; 1981; 38(3):369-77. PubMed ID: 7315473
    [No Abstract]   [Full Text] [Related]  

  • 32. Antagonism of the anticonvulsant action of phenytoin, phenobarbital and acetazolamide by 6-hydroxydopamine.
    Browning RA; Simonton RL
    Life Sci; 1978 Jun; 22(21):1921-9. PubMed ID: 672435
    [No Abstract]   [Full Text] [Related]  

  • 33. Anticonvulsant drugs and brain glucose.
    Gilbert JC; Gray P; Heaton GM
    Biochem Pharmacol; 1971 Jan; 20(1):240-3. PubMed ID: 5570638
    [No Abstract]   [Full Text] [Related]  

  • 34. Influence of antazoline and ketotifen on the anticonvulsant activity of conventional antiepileptics against maximal electroshock in mice.
    Swiader M; Wielosz M; Czuczwar SJ
    Eur Neuropsychopharmacol; 2004 Aug; 14(4):307-18. PubMed ID: 15163441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of bovine brain aldehyde reductase by anticonvulsant compounds in vitro.
    Erwin VG; Deitrich RA
    Biochem Pharmacol; 1973 Oct; 22(20):2615-24. PubMed ID: 4148709
    [No Abstract]   [Full Text] [Related]  

  • 36. [The effect of flunarizine on the anticonvulsant action of phenobarbital in maximal electroshock in the mouse].
    Fischer W
    Pharmazie; 1987 Nov; 42(11):743-4. PubMed ID: 3438342
    [No Abstract]   [Full Text] [Related]  

  • 37. Synthesis and anticonvulsant properties of new 1-(2-pyridinyl)- 3-substituted pyrrolidine-2,5-dione derivatives.
    Kamiński K; Obniska J
    Acta Pol Pharm; 2008; 65(4):457-65. PubMed ID: 19051587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1-Methyl-1,2,3,4-tetrahydroisoquinoline enhances the anticonvulsant action of carbamazepine and valproate in the mouse maximal electroshock seizure model.
    Luszczki JJ; Antkiewicz-Michaluk L; Czuczwar SJ
    Neuropharmacology; 2006 Feb; 50(2):133-42. PubMed ID: 16153667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The anticonvulsant action of inhibitors of carbonic anhydrase: relation to endogenous amines in brain.
    Gray WD; Rauh CE
    J Pharmacol Exp Ther; 1967 Jan; 155(1):127-34. PubMed ID: 6017334
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of substitution on anticonvulsant activity of some 5,5-diphenylhydantoin derivatives.
    Lange J; Lapszewicz J
    Acta Pol Pharm; 1990; 47(1-2):31-4. PubMed ID: 12959256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.